New research shows that asthmatics who have poor symptom control could be benefited by using a three-drug combination inhaler. The standard treatment for these patients is a two-drug combination of an inhaled corticosteroid (ICS) and a long acting beta 2 agonist (LABA). The third ingredient added to the mix is a long acting muscarinic antagonist, add the researchers. This combination successfully improved lung function and reduced exacerbations of asthma wrote the researchers.
from http://besthealthnews.com/2019/10/triple-drug-combo-inhaler-for-asthmatics-with-poor-symptom-control/?utm_source=rss&utm_medium=rss&utm_campaign=triple-drug-combo-inhaler-for-asthmatics-with-poor-symptom-control
from
https://healthnews010.tumblr.com/post/188083005428
No comments:
Post a Comment